Indonesia Set For Explosion In Number Of Hepatitis C Cases
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - The incidence of patients with hepatitis C is set to explode in Indonesia, with an estimated 7 million citizens currently infected expected to surge to 11 million people by the year 2016, according to experts at Frost & Sullivan
You may also be interested in...
Merck And Vertex Poised For Growth In Singapore's HCV Market As Medical Tourism Booms
SHANGHAI - Novel hepatitis C treatments from Merck and Vertex are expected to fare well in Singapore - with the proper marketing campaigns - due in part to increased medical tourism from neighboring Southeast Asian countries
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).